Murine intestinal crypt survival after combined taxol plus radiation exposure

Gynecologic Oncology

Volumn 63, Issue 2, 1996, Pages 180-183

  Lojun, S L ^a   Sigdestad, C P ^b   Connor, A M ^c   Spanos Jr , W J ^b   Bosscher, J R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CREMOPHOR; PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; GASTROINTESTINAL TOXICITY; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION;

EID: 0030298039     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0303     Document Type: Article

References (28)

1. 1. Rowinsky, E. K., Cazenave, L. A., and Donehower, R. C. Taxol: A novel investigational antineoplastic agent, J. Natl Cancer Inst. 82, 1247-1259 (1990).
2. 2. Rowinsky, I. K., Gilbert, M., and McGuire, W. P. Sequences of Taxol and cisplatin: A phase I and pharmacologic study, J. Clin. Oncol. 9, 1692-1703 (1991).
3. 3. Donehower, R. C., and Rowinsky, E. K. An overview of experience with Taxol (paclitaxel) in the USA, Cancer Treat. Rev. 19, 63-78 (1993).
4. 4. Manfredi, J. J., and Horwitz, S. B. Taxol: An antimitotic agent with a new mechanism of action, Pharmacol. Ther. 25, 83-125 (1984).
5. 5. Kumar, N. Taxol-induced polymerization of purified tubulin: Mechanism of action, J. Biol. Chem. 256, 10435-10441 (1981).
6. 6. Schiff, P. B., Fant, J., and Horwitz, S. B. Promotion of microtubule assembly in vitro by Taxol, Nature 277, 665-667 (1979).
7. 7. Glantz, M., Walhberg, L., Kim, L., Akerley, W., Mills, P., and Choy, H. Phase I study of weekly TAXOL and concurrent cranial radiation in adults with primary brain tumors. Proc. Am. Soc. Clin Oncol. 13, 183 (1994).
8. 8. Hainsworth, J. D., Miller, P., Menchise, A., Raefsky, E., and Greco, F. A. Treatment of locally advanced non-small cell lung cancer (NSCLC) with Taxol (1-hour infusion), cisplatin, etoposide, and radiation therapy (RT): A Phase II trial, Proc. Am. Soc. Clin. Oncol. 13, 1172 (1994).
9. 9. Withers, J. R., and Elkind, M. M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation, Int. J. Radiat. Biol. 17, 261-267 (1970).
10. 10. Withers, J. R., Mason, K., Reid, B. O., Dubravsky, N., Barkely, H. T., Brown, N. W., and Smathers, J. B. Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle, Cancer 34, 39-47 (1974).
11. 11. Sigdestad, C., P., and Scott, R. M. The effect of WR-2721 on intestinal crypt survival: 1.4-MeV X-rays, Radiat. Res. 62, 267-275 (1975).
12. 12. Hagemann, R. F., Sigdestad, C. P., and Lesher, S. Intestinal crypt survival and total and per crypt levels of proliferative cellularity following irradiation: Single X-ray exposure, Radiat. Res. 46, 533-546 (1971).
13. 13. Choy, J., Rodriguez, F. F., Koester, S., Hilsenbeck, S., and Von Hoff, D. D. Investigation of Taxol as a potential radiation sensitizer, Cancer 71, 3774-3778 (1993).
14. 14. Steren, A., Sevin, B. U., Perras, J., Angioli, R., Nguyen, H., Guerra, L., Koechli, O., and Averette, H. E. Taxol sensitizes human ovarian cancer cells to radiation, Gynecol. Oncol. 48, 252-258 (1993).
15. 15. Steren, A., Sevin, B. U., Perras, J., Ramos, R., Angioli, R., Nguyen, H., Koechli, O., and Averette, H. E. Taxol as a radiation sensitizer: A flow cytometric study, Gynecol. Oncol. 50, 89-93 (1993).
16. 16. Tishler, R. B., Geard, C. R., Hall, E. J., and Schiff, P. B. Taxol sensitizes human astrocytoma cells to radiation, Cancer Res. 52, 3495-3497 (1992).
17. 17. Tishler, R. B., Schiff, P. B., Geard, G. R., and Hall, E. J. Taxol: A novel radiation sensitizer, Radiat. Oncol. Biol. Phys. 22, 613-617 (1992).
18. 18. Geard, C. R., Jones, J. M., and Schiff, P. B. Taxol and radiation, Monogr. Natl. Cancer Inst. 15, 89-94 (1993).
19. 19. Stromberg, J. S., Lee, Y. J., Armour, E. P., Martinez, A. A., and Corry, P. M. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines, Cancer 75, 2262-2268 (1995).
20. 20. Liebmann, J., Cook, J. A., Fisher, J., and Teague, D. In vitro studies of Taxol as a radiation sensitizer in human tumor cells, J. Natl. Cancer Inst. 16, 441-446 (1994).
21. 21. Geard, C. R., and Jones, J. M. Radiation and Taxol effects on synchronized human cervical carcinoma cells, Int. J. Radiat. Oncol. Biol. Phys. 29, 565-569 (1994).
22. 22. Mason, K. A., Milas, L., and Peters, L. J. Effect of paclitaxel (Taxol) alone and in combination with radiation on the gastrointestinal mucosa, Int. J. Radiat. Oncol. Biol. Phys. 32, 1381-1389 (1995).
23. 23. Donaldson, K. L., Goolsby, G. L., and Wahl, A. F. Cytotoxicity of the anticancer agents cisplatin and Taxol during cell proliferation and the cell cycle, Int. J. Cancer 57, 847-855 (1994).
24. 24. Liebmann, J., Cook, J. A., Lipschultz, C., Teague, D., Fisher, J., and Mitchell, J. B. The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines, Cancer Chemother. Pharmacol. 33, 331-339 (1994).
25. 25. Schenken, L. L., Burholt, D. R., Hagemann, R. F., and Lesher, S. The modification of gastrointestinal tolerance and responses to abdominal irradiation by chemotherapeutic agents, Radiology 120, 417-420 (1976).
26. 26. Hei, T. K., and Hall, E. J. Taxol, radiation, and oncogenic transformation, Cancer Res. 53, 1368-1372 (1993).
27. 27. Hei, T. K., Piao, C. Q., Geard, C. R., and Hall, E. J. Taxol and ionizing radiation: Interaction and mechanisms, Int. J. Radiat. Oncol. Biol Phys. 29, 267-271 (1994).
28. 28. Liebmann, J., Cook, J. A., Fisher, J., Teague, D., and Mitchell, J. B. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol), Int. J. Radiat. Oncol. Biol. Phys. 29, 559-564 (1994).